Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U01AI142756)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1HG009490)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01EB022376)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM118062)
Howard Hughes Medical Institute (Liu investigatorship)
Article History
Received: 3 February 2020
Accepted: 15 May 2020
First Online: 22 June 2020
Competing interests
: Authors through the Broad Institute and Harvard University have filed patent applications on genome editing technologies, including base editing and prime editing. D.R.L. is a consultant and cofounder of Prime Medicine, Beam Therapeutics, Pairwise Plants and Editas Medicine, companies that use genome editing.